Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

Autor: Ten Hoorn, Sanne, Waasdorp, Cynthia, van Oijen, Martijn G H, Damhofer, Helene, Trinh, Anne, Zhao, Lan, Smits, Lisanne J H, Bootsma, Sanne, van Pelt, Gabi W, Mesker, Wilma E, Mol, Linda, Goey, Kaitlyn K H, Koopman, Miriam, Medema, Jan Paul, Tuynman, Jurriaan B, Zlobec, Inti, Punt, Cornelis J A, Vermeulen, Louis, Bijlsma, Maarten F

Publikováno v: Ten Hoorn, Sanne; Waasdorp, Cynthia; van Oijen, Martijn G H; Damhofer, Helene; Trinh, Anne; Zhao, Lan; Smits, Lisanne J H; Bootsma, Sanne; van Pelt, Gabi W; Mesker, Wilma E; Mol, Linda; Goey, Kaitlyn K H; Koopman, Miriam; Medema, Jan Paul; Tuynman, Jurriaan B; Zlobec, Inti; Punt, Cornelis J A; Vermeulen, Louis; Bijlsma, Maarten F (2022). Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer. BMC cancer, 22(1), p. 394. BioMed Central 10.1186/s12885-022-09436-0
ten Hoorn, S, Waasdorp, C, van Oijen, M G H, Damhofer, H, Trinh, A, Zhao, L, Smits, L J H, Bootsma, S, van Pelt, G W, Mesker, W E, Mol, L, Goey, K K H, Koopman, M, Medema, J P, Tuynman, J B, Zlobec, I, Punt, C J A, Vermeulen, L & Bijlsma, M F 2022, ' Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer ', BMC Cancer, vol. 22, no. 1, 394 . https://doi.org/10.1186/s12885-022-09436-0
BMC cancer, 22(1):394. BioMed Central
BMC Cancer, 22(1). BMC
BMC Cancer, 22(1):394. BioMed Central

Background Recently it has been recognized that stromal markers could be used as a clinically relevant biomarker for therapy response and prognosis. Here, we report on a serum marker for stromal activation, A Disintegrin and Metalloprotease 12 (ADAM1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9f80159b15dc7da3cafa0b96ca8a63e
https://boris.unibe.ch/169312/1/s12885-022-09436-0.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Supportive treatment and decision-making in a patient with severe anaemia when blood transfusion is not an option].

Autor: Goey KKH; Diakonessenhuis, Utrecht: Afd. Interne Geneeskunde.; Contact: Kaitlyn K.H. Goey (k.k.h.goey@umcutrecht.nl)., Aper SJA; Diakonessenhuis, Utrecht: Afd. Laboratorium Klinische Chemie, Hematologie en Immunologie., van Tuyl SBAC; Diakonessenhuis, Utrecht: Afd. Maag-Darm-Leverziekten., Geesing JMJ; Diakonessenhuis, Utrecht: Afd. Maag-Darm-Leverziekten., Logtenberg SJJ; Diakonessenhuis, Utrecht: Afd. Interne Geneeskunde.

Publikováno v: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2022 Mar 21; Vol. 166. Date of Electronic Publication: 2022 Mar 21.